Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Understanding Reasonable Fear vs. Credible Fear Interviews: A Critical Guide for Immigrants Facing Removal

Client Alert

Washington, D.C. – In a timely new article, Rob Ratliff, Immigration Attorney and former Immigration Judge, clarifies the differences between Reasonable Fear Interviews and Credible Fear Interviews, essential processes for noncitizens fearing persecution or torture. Published at www.removal-defense.com, the article explains concepts central to recent judicial rulings, including U.S. District Judge Brian Murphy’s order addressing the Trump administration’s unlawful deportations to South Sudan, which violated his April 18, 2025, injunction (U.S. District Court, Massachusetts).

Reasonable Fear Interviews apply to individuals with prior removal orders, like those with aggravated felonies or reentry after deportation (INA § 238(b), § 241(a)(5)), assessing a “reasonable possibility” of persecution or torture. Successful cases lead to withholding-only proceedings for withholding of removal or Convention Against Torture (CAT) protection (8 CFR § 208.31). Credible Fear Interviews target those in expedited removal, like border apprehensions, requiring a lower “significant possibility” of eligibility for asylum, withholding, or CAT protection, potentially leading to an Asylum Merits Interview or removal proceedings (INA § 235(b)(1); 8 CFR § 208.30).

Both allow an immigration judge (IJ) review of negative findings, but the IJ review is final with no appeal (8 CFR § 1208.31(g); 8 CFR § 1003.42), unless a new hearing is granted. An alien may consult with counsel prior to a hearing with an IJ or asylum officer, but during asylum officer interviews, attorneys are limited to observation and consultation (8 CFR § 208.30(d)(4); 8 CFR § 208.31(c)). It is the discretion of the IJ or asylum officer, is the attorney is permitted provide brief argument on behalf of their client. Notice for a hearing is provided via Form I-863 or Notices to Appear (8 CFR § 1208.31(e); 8 CFR § 1239.1).

“Judge Murphy’s ruling underscores the due process issues in these screenings,” said Ratliff. “Our article connects these processes to real-world cases.” Read the full analysis at www.removal-defense.com.


CMS Requires Providers to Use an Updated Advance Beneficiary Notice (ABN) Form by May 12, 2026

CMS has released an updated Advance Beneficiary Notice of Noncoverage (ABN), Form CMS-R-131, that all providers and suppliers must begin using by May 12, 2026. The revised form includes clearer language and formatting updates intended to improve patient understanding and compliance.

CMS and Ohio Ramp Up Fraud Enforcement in Home Health and Hospice

CMS and Ohio have launched sweeping new fraud prevention initiatives targeting home health and hospice providers, signaling a period of heightened scrutiny for enrollment, billing, documentation, and EVV compliance. While aimed at combating fraud, these measures also create significant operational and due process risks for compliant agencies, making proactive compliance programs, auditing, and governance more important than ever.

MYTH BUSTER: Can a New Chiropractor Bill Under An Established Chiropractor’s NPI?

Many chiropractic practices mistakenly believe a newly hired chiropractor can bill under an established chiropractor’s NPI while waiting for credentialing approval. In most cases, this is not permitted. Claims should be submitted under the NPI of the chiropractor who actually rendered the service to avoid compliance risks, including potential False Claims Act exposure. This article outlines key billing rules, common exceptions, and practical compliance tips for chiropractic practices.

RNs and APRNs Take Note: Ohio Board of Nursing Mandates a New CE Reporting Period

Ohio’s Board of Nursing has updated the continuing education reporting period for RNs and APRNs. Beginning March 26, 2026, CE credits must be completed between July 1 and June 30 of odd-numbered years, replacing the previous November to October timeframe.

Ohio Med Spas: Peptide Do's and Do Not's

Recent guidance from the Ohio Board of Pharmacy outlines key compliance requirements for med spas using peptides. While some peptide drugs are FDA approved, others are not or cannot be compounded. Med spa operators should ensure they source medications from licensed suppliers, avoid non-approved or “research use only” products, and follow all compounding and storage regulations to maintain compliance and avoid enforcement actions.